Quick Answer
Avalon GloboCare Corp. reported R&D Expense of $109.6 thousand for fiscal year 2023.
Avalon GloboCare Corp. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2023 | $109.6K | -85.0% |
| 2022 | $731.3K | -28.7% |
| 2021 | $1.03M | +16.0% |
| 2020 | $883.9K | -50.4% |
| 2019 | $1.78M | +4461.8% |
| 2018 | $39.1K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | $17.8K | -93.0% | -80.7% |
| March 31, 2023 | $92.3K | -20.9% | -45.8% |
| September 30, 2022 | $170.4K | -24.0% | -33.0% |
| June 30, 2022 | $254.5K | +6.6% | +118.1% |
| March 31, 2022 | $116.7K | -45.3% | -47.9% |
| September 30, 2021 | $224.1K | -6.0% | -6.2% |
| June 30, 2021 | $238.8K | +48.2% | +12.0% |
| March 31, 2021 | $213.2K | -22.6% | -10.6% |
- Avalon GloboCare Corp. showed a decrease of -85.0% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2023 period, Avalon GloboCare Corp.’s r&d expense has grown by 180.6% (from $39.1 thousand to $109.6 thousand).
- The most recent figure is from Avalon GloboCare Corp.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 15, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: